Most people do not recognize cancer warning signs
the ONA take:
According to a new study published in the journal PLOS ONE, most people ignore cancer "alarm" symptoms. Researchers at University College London in London, United Kingdom, asked 1,724 participants aged 50 years and over whether they had experienced and of 17 cancer "alarm" symptoms.
Some symptoms included in the questionnaire were changes in mole appearance, difficulty swallowing, persistent change in bowel habits, unexplained bleeding, unexplained cough, unexplained lumps, and unexplained weight loss. Participants were not informed as to which symptoms are warning signs of cancer.
They were asked what they the thought to be the cause of any symptoms they experienced, as well as how serious they deemed the symptoms to be and if they visited the doctor as a result.
Of all respondents of the questionnaire, 53% reported experiencing at least one cancer warning symptom in the last 3 months and only 2% considered the warning symptoms to be cancer-related. Persistent cough and persistent change in bowel habits were the most common cancer warning signs experienced; unexplained weight loss and difficulty swallowing were the least.
Results showed that 59% of participants who experienced cancer signs visited a doctor. The findings suggest that many people who experience cancer signs do not realize the seriousness of their symptoms.
Most people ignore cancer "alarm" symptoms.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|